YOLFTbeta
Moberg Pharma AB (publ)

Moberg Pharma AB (publ)

MOB · ST · Healthcare / Drug Manufacturers - Specialty & Generic

10.68SEK+0.30 (+2.89%)

Price History

Full chart

Market Stats

Previous Close10.38
Open10.48
Day Range10.26 – 10.68
52-Week Range7.53 – 14.12
Volume50.31K
Market Cap525.59M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.46
Dividend Yield0.00%
Beta1.09
50-Day Avg10.70
200-Day Avg10.24

About

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. It has license agreement with Karo Healthcare for distribution in European market. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Anna Ljung BA, M.Sc.
  • Employees5
  • HeadquartersGustavslundsvägen 42, Bromma, Sweden, 167 51, Sweden
  • Websitehttps://www.mobergpharma.se

Leadership

  • Ms. Anna Ljung BA, M.Sc.Chief Executive Officer · b. 1980
  • Ms. Marie MobergCo-Founder
  • Mr. Mark BeveridgeVice President of Finance & CFO · b. 1978
  • Dr. Amir Tavakkol Ph.D.Chief Scientific Officer · b. 1956
  • Gunilla WengströmSenior Director of Sales & Marketing
  • Ms. Helena JanssonChief Business Officer & Vice CEO · b. 1975
  • Vaidrius NavikasChief Medical Officer · b. 1966

Financials

Income Statement

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-1.62M8.51M55.94M112.47M157.39M200.18M285.57M334.30M439.03M439.04M30.82M33.66M209.68M207.00K273.15M9.81M13.54M
Growth (%)--+426.60%+557.24%+101.04%+39.94%+27.19%+42.65%+17.07%+31.33%+0.00%-92.98%+9.19%+522.97%-99.90%+131858.45%-96.41%+37.99%
Cost of Revenue--2.85M16.63M24.88M39.97M49.06M71.92M101.36M125.18M104.44M-2.87M1512.58M2.58M2.10M3.50M5.86M
Gross Profit-1.62M5.66M39.31M87.59M117.42M151.12M213.65M232.95M313.85M334.61M33.70M33.66M-2.58M-2.38M-2.10M6.32M7.68M
Gross Margin-100.00%66.53%70.27%77.88%74.61%75.49%74.81%69.68%71.49%76.21%109.31%100.00%-1.23%-1147.34%-0.77%64.37%56.73%
Operating Expense-25.89M35.78M46.91M75.00M131.48M133.89M178.46M170.78M262.78M269.79M20.79M55.34M17.15M18.14M26.42M331.14M35.68M
Operating Income-36.70M-24.28M-30.12M-7.60M12.59M-14.05M17.23M35.18M62.17M51.08M64.82M12.91M-21.68M-19.73M-20.52M-28.52M-324.83M-28.00M
Operating Margin--1501.91%-353.85%-13.58%11.20%-8.93%8.61%12.32%18.60%11.63%14.76%41.88%-64.42%-9.41%-9911.59%-10.44%-3310.88%-206.80%
EBITDA-35.20M-24.06M-29.81M-5.89M15.68M-7.79M25.96M46.24M37.29M73.59M94.33M--19.15M-17.26M-16.86M-26.42M-18.93M-26.39M
EBITDA Margin--1488.56%-350.21%-10.53%13.94%-4.95%12.97%16.19%11.16%16.76%21.49%--56.89%-8.23%-8144.44%-9.67%-192.93%-194.93%
Net Income-35.34M-24.23M-31.03M-6.38M35.81M-11.36M12.27M25.54M32.67M11.16M19.84M7.96M-19.03M-16.22M-15.71M-21.09M-255.11M-27.24M
Net Income Margin--1499.35%-364.56%-11.41%31.84%-7.22%6.13%8.94%9.77%2.54%4.52%25.82%-56.53%-7.74%-7589.37%-7.72%-2600.25%-201.18%
R&D26.19M15.71M18.99M26.81M54.23M56.87M46.48M48.90M42.73M49.02M58.33M-24.00M21.89M21.23M2.38M302.23M3.54M
R&D as % of Total Revenue-971.70%223.13%47.92%48.22%36.13%23.22%17.12%12.78%11.17%13.29%-71.30%10.44%10257.97%0.87%3080.52%26.15%
Interest Expense57.04K42.18K1.08M28.00K285.00K2.28M1.32M455.00K19.79M36.54M36.31M01.84M129.00K71.00K260.00K228.00K178.00K
Interest Expense % of Total Revenue-2.61%12.65%0.05%0.25%1.45%0.66%0.16%5.92%8.32%8.27%0.00%5.47%0.06%34.30%0.10%2.32%1.31%

Balance Sheet

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.59M35.30M12.38M92.45M280.76M271.61M359.72M397.45M1.23B1.22B1.25B130.59M480.58M450.89M564.42M634.73M706.09M682.26M
Total Liabilities7.36M5.09M11.69M15.67M102.53M70.11M55.97M44.63M670.55M670.85M657.60M24.91M85.00M16.84M30.84M24.01M19.27M17.04M
Total Equity15.23M30.21M687.70K76.79M178.23M201.49M303.75M352.82M561.63M552.41M594.02M105.68M387.87M434.05M533.58M610.73M686.82M665.22M
Cash20.20M33.08M2.76M74.05M53.42M26.44M61.76M44.66M85.40M118.74M110.08M30.84M19.29M101.95M124.85M59.85M293.29M230.95M
Total Debt677.50K302.50K150.00K-40.00M30.00M16.67M3.33M589.04M591.79M594.52M3.33M20.14M18.95M13.37M4.74M4.14M2.55M
Net Debt-19.53M-32.78M-2.61M-74.05M-13.42M3.56M-45.10M-41.32M503.64M473.05M484.43M--11.89M-98.02M-118.75M-55.82M-289.15M-227.53M

Cash Flow

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-34.89M-25.26M-30.41M-9.02M9.48M-3.15M16.16M30.72M-17.94M53.82M73.89M3.95M-29.93M-15.30M-16.84M-33.20M-16.47M-17.49M
Investing Cash Flow-445.65K-23.08K-158.64K-535.00K-97.70M-47.16M-24.50M-43.88M-680.66M-36.05M2.80B-55.02M-43.93M-41.31M-16.84M-124.12M-73.55M-43.19M
Financing Cash Flow20.46M38.16M253.82K80.85M67.59M24.05M42.60M-4.21M737.95M858.00K-666.00K-831.79M28.00M129.97M107.81M92.33M322.76M-1.66M
Capital Expenditure444.65K23.08K158.64K535.00K630.00K30.50M7.27M43.88M680.66M19.68M83.64M2.87M33.49M31.31M68.07M124.12M73.55M17.49M
Free Cash Flow-35.34M-25.28M-30.57M-9.55M8.85M-33.65M8.89M-13.16M-698.60M34.14M-9.75M--63.42M-46.60M-84.91M-157.32M-90.02M-60.68M
Dividends Paid----------576.79M-558.27M-----
FCF to OCF101.27%100.09%100.52%105.93%93.35%1068.25%55.01%-42.85%3893.86%63.44%-13.20%-211.93%304.69%504.18%473.79%546.59%346.96%
Dividend Paid to FCF-----------5915.85%--880.29%-----

Earnings

Report DateJun 1, 2011Aug 12, 2011Oct 28, 2011Feb 9, 2012Apr 23, 2012Aug 28, 2012Oct 24, 2012Feb 4, 2013May 21, 2013Aug 6, 2013Nov 5, 2013Feb 20, 2014May 13, 2014Aug 13, 2014Nov 14, 2014Feb 27, 2015May 11, 2015Aug 11, 2015Nov 10, 2015Feb 17, 2016May 10, 2016Aug 9, 2016Nov 8, 2016Feb 14, 2017May 9, 2017Aug 8, 2017Nov 13, 2017Feb 13, 2018May 8, 2018Aug 7, 2018Nov 6, 2018Feb 11, 2019Nov 19, 2019Feb 11, 2020May 12, 2020Aug 11, 2020Nov 10, 2020Feb 9, 2021May 11, 2021Aug 10, 2021Nov 9, 2021Feb 8, 2022May 10, 2022Aug 9, 2022Nov 8, 2022Feb 7, 2023May 9, 2023Aug 3, 2023Nov 7, 2023Feb 13, 2024May 7, 2024Aug 13, 2024Nov 12, 2024Feb 11, 2025May 13, 2025Aug 12, 2025Nov 11, 2025Feb 9, 2026May 11, 2026Aug 14, 2026
EPS Estimate---14.90--1.90-1.506.25-1.053.605.90-0.75-1.75-1.301.00-0.094.305.752.603.902.759.472.233.47-3.302.296.141.31-1.50-1.471.394.910.04-0.44-0.340.20-----------------0.10-0.12--0.10-0.10---
EPS Actual-5.80-5.995.903.2341.700.832.90-6.30-0.70-3.90-3.40-0.403.403.303.10-0.027.503.806.100.30-4.0019.608.90-1.70-1.70-4.507.105.501.200.622.106.201.56-0.19-0.18-0.28-0.22-0.333.02-0.490.47-0.08-0.09-0.09-0.10-0.06-0.04-0.32-0.34-0.23-0.23-0.13-0.031.21-0.06-0.16-0.09-0.27-0.03-0.07
Surprise--139.60%-2294.74%-93.33%-200.80%33.33%-208.33%-157.63%46.67%294.29%353.85%210.00%77.78%74.42%-33.91%134.62%-92.31%-245.45%106.97%299.10%-148.99%48.48%-296.51%15.64%319.85%180.00%142.18%51.08%26.27%3791.00%56.91%46.38%-239.10%----------------70.00%1108.33%--60.00%10.00%---
Timing--Pre-market-After-hours-After-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap525.59M
Enterprise Value143.88M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales31.36
Price / Book0.78
EPS-0.46
Book Value19.53
Revenue (TTM)16.76M
Gross Profit (TTM)10.44M
EBITDA-19.89M
Profit Margin-128.96%
Operating Margin-81.95%
Return on Equity-3.22%
Return on Assets-1.86%
Shares Outstanding47.18M
Shares Float37.63M
Beta1.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 11, 20233:2
  • May 24, 20231:10
  • May 10, 2022697:673
  • Dec 2, 20201098:971